2014 Community-Acquired Pneumonia Pulse
2014 Community-Acquired Pneumonia Pulse
$599.00
We performed a 5-question survey of 20 infectious disease (ID) specialists in the U.S. to gauge current prescribing practices for community-acquired pneumonia (CAP) and gauge interest in new drugs/new drug candidates.
Publisher: Biomedtracker
- Description
- Samples
We performed a 5-question survey of 20 infectious disease (ID) specialists in the U.S. to gauge current prescribing practices for community-acquired pneumonia (CAP) and gauge interest in new drugs/new drug candidates. Topics covered in this survey include:
- Current usage of antibiotics for CAP, grouped by antibiotic class
- Bacterial pathogens of greatest current concern in CAP
- Prescribing preferences following failure of 1st-line empiric CAP therapy
- Potential prescribing levels for CAP drugs with greater potency than existing (generic) drugs but higher price
Appendix : Development status for Selected Antibiotics
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
2015 Chronic Lymphocytic Leukemia (CLL) Pulse 
Sign up to the